STOCK MARKET BSE NSE

Sree Chitra's technology for efficient cancer treatment wins US patent

The technology is for sustained delivery of a potential chemotherapeutic molecule around cancer tissues.

Published: 13th January 2020 01:25 AM  |   Last Updated: 13th January 2020 01:25 AM   |  A+A-

cancer

For representational purposes

By Express News Service

THIRUVANANTHAPURAM: A novel technology for cancer treatment developed by the Sree Chitra Tirunal Institute for Medical Sciences has won a US patent. The project funded by the Indian Council for Medical Research was led by Dr Lissy Krishnan and team of the Biomedical Technology wing of SCTIMST.

The technology is for sustained delivery of a potential chemotherapeutic molecule around cancer tissues. “Oral and intravenous chemotherapy are effective but they also kill normal cells which cause serious side effects. But continuous local delivery of anti-cancer drug directly on cancer tissue will avoid the drugs affecting normal cells,” said a statement.

Stay up to date on all the latest Thiruvananthapuram news with The New Indian Express App. Download now

Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp